These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 23259622)

  • 1. Juvenile idiopathic arthritis: an update for the clinician.
    Kahn P
    Bull NYU Hosp Jt Dis; 2012; 70(3):152-66. PubMed ID: 23259622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Juvenile idiopathic arthritis - an update on pharmacotherapy.
    Kahn P
    Bull NYU Hosp Jt Dis; 2011; 69(3):264-76. PubMed ID: 22035441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Juvenile idiopathic arthritis - what the clinician needs to know.
    Kahn PJ
    Bull Hosp Jt Dis (2013); 2013; 71(3):194-9. PubMed ID: 24151944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Juvenile idiopathic arthritis--current and future therapies.
    Kahn P
    Bull NYU Hosp Jt Dis; 2009; 67(3):291-302. PubMed ID: 19852753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on biologicals for treatment of juvenile idiopathic arthritis.
    Horneff G
    Expert Opin Biol Ther; 2013 Mar; 13(3):361-76. PubMed ID: 23289865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parents' preferences for drug treatments in juvenile idiopathic arthritis: a discrete choice experiment.
    Burnett HF; Regier DA; Feldman BM; Miller FA; Ungar WJ
    Arthritis Care Res (Hoboken); 2012 Sep; 64(9):1382-91. PubMed ID: 22504893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Juvenile idiopathic arthritis: an update.
    Olson JC
    WMJ; 2003; 102(7):45-50. PubMed ID: 14711024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ongoing disease activity and changing categories in a long-term nordic cohort study of juvenile idiopathic arthritis.
    Nordal E; Zak M; Aalto K; Berntson L; Fasth A; Herlin T; Lahdenne P; Nielsen S; Straume B; Rygg M;
    Arthritis Rheum; 2011 Sep; 63(9):2809-18. PubMed ID: 21560116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on treatment of arthritis in children: new treatments, new goals.
    Lovell DJ
    Bull NYU Hosp Jt Dis; 2006; 64(1-2):72-6. PubMed ID: 17121494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Juvenile idiopathic arthritis.
    Gowdie PJ; Tse SM
    Pediatr Clin North Am; 2012 Apr; 59(2):301-27. PubMed ID: 22560572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New advances in the management of juvenile idiopathic arthritis--2: the era of biologicals.
    Beresford MW; Baildam EM
    Arch Dis Child Educ Pract Ed; 2009 Oct; 94(5):151-6. PubMed ID: 19770495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of malignancy in children with juvenile idiopathic arthritis not treated with biologic agents.
    Nordstrom BL; Mines D; Gu Y; Mercaldi C; Aquino P; Harrison MJ
    Arthritis Care Res (Hoboken); 2012 Sep; 64(9):1357-64. PubMed ID: 22511558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumour necrosis factor-blocking agents in persistent oligoarticular juvenile idiopathic arthritis: results from the Dutch Arthritis and Biologicals in Children Register.
    Anink J; Otten MH; Prince FH; Hoppenreijs EP; Wulffraat NM; Swart JF; ten Cate R; van Rossum MA; van den Berg JM; Dolman KM; Koopman-Keemink Y; Armbrust W; Kamphuis S; van Pelt PA; Gorter SL; van Suijlekom-Smit LW
    Rheumatology (Oxford); 2013 Apr; 52(4):712-7. PubMed ID: 23267169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcomes after withdrawal of anti-tumor necrosis factor α therapy in patients with juvenile idiopathic arthritis: a twelve-year experience.
    Baszis K; Garbutt J; Toib D; Mao J; King A; White A; French A
    Arthritis Rheum; 2011 Oct; 63(10):3163-8. PubMed ID: 21702011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Juvenile idiopathic arthritis: classification, clinical presentation and current treatments.
    Dannecker GE; Quartier P
    Horm Res; 2009 Nov; 72 Suppl 1():4-12. PubMed ID: 19940489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Good help from modern treatment of juvenile idiopathic arthritis].
    Berntson L; Hagelberg S; Månsson B; Fasth A
    Lakartidningen; 2013 Apr 10-16; 110(15):754-7. PubMed ID: 23662535
    [No Abstract]   [Full Text] [Related]  

  • 17. Cost-effectiveness of biologics in polyarticular-course juvenile idiopathic arthritis patients unresponsive to disease-modifying antirheumatic drugs.
    Ungar WJ; Costa V; Hancock-Howard R; Feldman BM; Laxer RM
    Arthritis Care Res (Hoboken); 2011 Jan; 63(1):111-9. PubMed ID: 20740607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical course and prognostic value of disease activity in the first two years in different subtypes of juvenile idiopathic arthritis.
    Albers HM; Brinkman DM; Kamphuis SS; van Suijlekom-Smit LW; van Rossum MA; Hoppenreijs EP; Girschick HJ; Wouters C; Saurenmann RK; Houwing-Duistermaat JJ; Huizinga TW; Schilham MW; ten Cate R
    Arthritis Care Res (Hoboken); 2010 Feb; 62(2):204-12. PubMed ID: 20191519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early outcomes and improvement of patients with juvenile idiopathic arthritis enrolled in a Canadian multicenter inception cohort.
    Oen K; Duffy CM; Tse SM; Ramsey S; Ellsworth J; Chédeville G; Chetaille AL; Saint-Cyr C; Cabral DA; Spiegel LR; Schneider R; Lang B; Huber AM; Dancey P; Silverman E; Rosenberg AM; Cameron B; Johnson N; Dorval J; Scuccimarri R; Campillo S; Petty RE; Duffy KN; Boire G; Haddad E; Houghton K; Laxer R; Turvey SE; Miettunen P; Gross K; Guzman J; Benseler S; Feldman BM; Espinosa V; Yeung RS; Tucker L
    Arthritis Care Res (Hoboken); 2010 Apr; 62(4):527-36. PubMed ID: 20391508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Juvenile idiopathic arthritis: state of the art and future perspectives.
    Martini A; Lovell DJ
    Ann Rheum Dis; 2010 Jul; 69(7):1260-3. PubMed ID: 20525835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.